It is time for Indian pharma companies to brace for heightened scrutiny as the US drug regulator ups the ante on standards.
November 15, 2015: Dr Reddy’s Laboratories, India’s only New York Stock Exchange-listed pharma company and among the top three players from India, receives a mail from the US Food and Drugs Administration (USFDA) about an inspection the latter carried out of three Dr Reddy’s manufacturing facilities in Andhra Pradesh and Telangana. “We identified significant deviations from current good manufacturing practice for the manufacture of active pharmaceutical ingredients,” it says. It then gets down to details, which include some rather surprising specifics like: “Because the conveyor belt was not operational (at one of the units), an operator manually intervened.....Each of these manual interventions risk compromising the sterility of the product.” And again: “During the inspection, the presence of an uncontrolled ‘custom QC laboratory’ was discovered by our inspection team. The existence of this laboratory was previously unknown to the FDA…”
December 17, 2015: India’s biggest pharma company, Sun Pharma, gets a mail from the USFDA pertaining to an inspection of one of its largest units in Halol, Gujarat, and one of the observations in the letter is: “The floors, walls and ceilings in your aseptic processing area were not maintained as smooth, hard surfaces that were easily cleaned. Our investigator documented the presence of leaks in the form of water stains and ceiling damage in the parenteral (injectables or infusions) manufacturing area personnel corridor. The FDA investigator observed buckets with water collected from ceiling leaks and other leaks in this manufacturing area…”
This story is from the March 13, 2016 edition of Business Today.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the March 13, 2016 edition of Business Today.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
GROWTH CHALLENGE
With a new CEO at the helm, IT major Wipro is trying to send out a word of assurance to its employees and investors
UNRAVELLING MEGHA
After Megha Engineering's name figured in the list of electoral bond buyers, there was unbridled curiosity about its business, promoters and just about everything. Here are the details
Picking Up The Paytm Pieces
Paytm Founder Vijay Shekhar Sharma Is Back In The Trenches After Rbi's Recent Action Left Him Without A Banking Platform. There Are Still Some Opportunities, But He Will Have To Move Swiftly To Grab Them
PMS Vs MF The Big Fight
How do mutual funds and portfolio management services match up? Know the score on structure, rules, entry fees, charges, and tax perks to pick the right path for your financial journey
Four Levers Of Enterprise AI Strategy
Wide-scale private sector AI deployment and new AI-based business opportunities and ecosystems can truly supercharge the Indian economy
"Don't let a unique chance slip by"
JEFF MAGGIONCALDA | CHIEF EXECUTIVE OFFICER | COURSERA
THE INCOMING DISRUPTION
The disruption in the industrial sector is still unknown, but inevitable. Companies need to wake up
THE WHEEL WHISPERER
For Manan Shah, Managing Director of MICL Group, luxury cars are not about showcasing one's wealth or status. It is about personal well-being
TRIPPING WITH TECH
A road trip is an adventure like no other. While you take in the experience, get some peace of mind with these nifty gadgets
Transforming Spaces
WHETHER YOU WANT TO REDECORATE YOUR BEDROOM OR HALLWAY, A GORGEOUS WALLPAPER ADDS FLAIR TO YOUR HOME AND ALLOWS YOU TO STAMP YOUR STYLE IN YOUR NEW ABODE